|
Originally published In Press as doi:10.1074/jbc.M208448200 on October 1, 2002
J. Biol. Chem., Vol. 277, Issue 50, 48130-48138, December 13, 2002
Modulation of the ERG K+ Current by the Tyrosine
Phosphatase, SHP-1*
Francisco S.
Cayabyab §¶,
Florence W. L.
Tsui , and
Lyanne C.
Schlichter §**
From the Cellular and Molecular Biology Division,
Toronto Western Research Institute, the § Department of
Physiology and the Department of Immunology, University of
Toronto, Toronto, Ontario M5T 2S8, Canada
We reported previously (Cayabyab, F. S., and Schlichter, L. C. (2002) J. Biol. Chem.
277, 13673-13681) a functional interaction between the ERG-1
K+ channel and Src tyrosine kinase, which increased the
current. We now show that the tyrosine phosphatase, SHP-1, which is
present in microglia, is increased after brain damage, and is activated by colony-stimulating factor-1, associates with ERG-1 and regulates the
current. Patch clamp recordings from the MLS-9 microglia cells were
made with pipette solutions containing a recombinant SHP-1 protein:
wild type (SHP-1 wild type (wt)), catalytically active (SHP-1 S6), or
the substrate-trapping mutant (SHP-1 Cys Ser). SHP-1 wt and
SHP-1 S6 proteins decreased the current, an effect that was reversed by
the phosphatase inhibitor, pervanadate, whereas SHP-1 Cys Ser
increased the current. Moreover, transient transfection with cDNA
for SHP-1 wt or SHP-1 S6 decreased the ERG current without decreasing
the protein level. Tyrosine phosphorylation of ERG-1 was decreased by
transfection with SHP-1 wt and increased by SHP-1 Cys Ser. The
decrease in current by active SHP-1 was partly attributed to changes in
the voltage dependence of activation and steady-state conductance,
whereas inactivation kinetics and voltage dependence were not affected.
Our results show that ERG-1 is a SHP-1 substrate constituting the first
report that an ion current is regulated by SHP-1.
*
This work was supported in part by Heart and Stroke
Foundation of Ontario Grant T-3726, the Canadian Institutes for Health Research Grant MT-13657 (to L. C. S.), and National Cancer Institute of Canada Grant 11044 (to F. W. L. T.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Recipient of a Heart and Stroke Foundation of Canada Research
traineeship. Present address: School of Kinesiology, Faculty of Applied
Sciences, Simon Fraser University, Academic Quadrangle K9626, 8888 University Drive, Burnaby, British Columbia V5A 1S6, Canada.
**
To whom correspondence should be addressed: MC 9-415, Toronto
Western Hospital, 399 Bathurst Street, Toronto, Ontario M5T 2S8,
Canada. Tel.: 416-603-5800 (ext. 2052); Fax: 416-603-5745; E-mail:
schlicht@uhnres.utoronto.ca.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. L. Cockerill, A. B. Tobin, I. Torrecilla, G. B. Willars, N. B. Standen, and J. S. Mitcheson
Modulation of hERG potassium currents in HEK-293 cells by protein kinase C. Evidence for direct phosphorylation of pore forming subunits
J. Physiol.,
June 1, 2007;
581(2):
479 - 493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Hirdes, L. F. Horowitz, and B. Hille
Muscarinic modulation of erg potassium current
J. Physiol.,
August 15, 2004;
559(1):
67 - 84.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|